Skip to content
OpenCapital
Get started

Vivani Medical VANI Q4 2025 Annual earnings

Reported March 26, 2026

Diluted EPS-$0.09In line
EPS estimate-$0.09

Next report

Aug 12, 2026 (In 3 weeks)
EPS estimate-$0.08

Financials

Q4 2025

Income statement

See full
Operating income-$6.8M-5.4%
Net income-$6.6M-9.6%
EPS (diluted)-$0.09+18.2%

Balance sheet

See full
Cash & equivalents$15.4M-21.7%
Total debt$18.9M-2.4%
Total equity$15.7M-10.7%
Total assets$39.4M-5.2%

Cash flow

See full
Operating cash flow-$6.7M-15.6%
CapEx$274.0K-7.4%
Free cash flow-$7.0M-14.5%

Valuation & ratios

Valuation

as of 12/31/25
See full
Market cap$89.73M+30.6%
Enterprise value$93.16M+36.3%

Returns & leverage

See full
Return on equity-159.6%+69.7pp
Debt / equity1.2×+0.1×
Current ratio2.7×-0.7×

Versus estimates

Revenue

Q4 2024$398.0K

Diluted EPS

Q1 2026-$0.08In line
Q4 2025-$0.09In line
Q3 2025-$0.11Beat by $0.01Q2 2025-$0.12Miss by $0.02Q1 2025-$0.11Miss by $0.01Q4 2024-$0.11Miss by $0.01

Ask the moment Vivani Medical reports.

Connect your AI and ask the moment the filing drops. It reads the release, surfaces what management said, and gives you its own read.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

When did Vivani Medical report Q4 2025 earnings?
Vivani Medical (VANI) reported Q4 2025 earnings on March 26, 2026.
What were Vivani Medical's Q4 2025 revenue and EPS?
Vivani Medical reported diluted EPS of $-0.09 for Q4 2025.
Did Vivani Medical beat estimates in Q4 2025?
EPS beat the consensus estimate of $-0.09 by $0.00.
How did Vivani Medical's Q4 2025 results compare year-over-year?
Compared to the same quarter a year prior, diluted EPS grew 18.2% from $-0.11.
Where can I find Vivani Medical's Q4 2025 SEC filings?
You can read the 8-K earnings release (0001753926-26-000550) and the 10-K periodic report (0001753926-26-000548) directly on SEC EDGAR. The filing index links above go to sec.gov.